Jay D. Keasling is a professor of chemical engineering and bioengineering at the University of California, Berkeley. He is also associate laboratory director for biosciences at the Lawrence Berkeley National Laboratory and chief executive officer of the Joint BioEnergy Institute. He is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering. Keasling was elected a member of the National Academy of Engineering in 2010 for developing synthetic biology tools to engineer the antimalarial drug artemisinin. Source: Wikipedia (en)